Procter and Gamble: Inspiring Success
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 1 Mar-2006
DOI: 10.3833/pdr.v2006.i69.544 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Procter and Gamble Pharmaceuticals announced on the first day of February 2006 that the company had signed an agreement with Washington-based biotechnology company Nastech Pharmaceutical to develop and commercialise an inhaled formulation of the naturally occurring parathyroid hormone (PTH) for the treatment of osteoporosis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS